Behavioral animal models of depression.

Neuroscience Bulletin
Hua-Cheng YanTian-Ming Gao

Abstract

Depression is a chronic, recurring and potentially life-threatening illness that affects up to 20% of the population across the world. Despite its prevalence and considerable impact on human, little is known about its pathogenesis. One of the major reasons is the restricted availability of validated animal models due to the absence of consensus on the pathology and etiology of depression. Besides, some core symptoms such as depressed mood, feeling of worthlessness, and recurring thoughts of death or suicide, are impossible to be modeled on laboratory animals. Currently, the criteria for identifying animal models of depression rely on either of the 2 principles: actions of known antidepressants and responses to stress. This review mainly focuses on the most widely used animal models of depression, including learned helplessness, chronic mild stress, and social defeat paradigms. Also, the behavioral tests for screening antidepressants, such as forced swimming test and tail suspension test, are also discussed. The advantages and major drawbacks of each model are evaluated. In prospective, new techniques that will be beneficial for developing novel animal models or detecting depression are discussed.

References

Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Oct 1, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Jan 1, 1992·Neuroscience and Biobehavioral Reviews·P WillnerM Papp
Feb 1, 1991·Pharmacology, Biochemistry, and Behavior·N N KudryavtsevaL A Koryakina
Feb 1, 1991·Physiology & Behavior·J AdrienP Martin
Sep 1, 1989·Biological Psychiatry·L GreenbergF A Henn
Jan 1, 1986·Annals of the New York Academy of Sciences·W T McKinney
Feb 1, 1967·Journal of Comparative and Physiological Psychology·J B Overmier, M E Seligman
May 1, 1967·Journal of Experimental Psychology·M E Seligman, S F Maier
Jan 1, 1984·Psychopharmacology·P Willner
Jan 1, 1981·Neuroscience and Biobehavioral Reviews·R J KatzB J Carroll
Jan 1, 1981·Neuroscience and Biobehavioral Reviews·R J Katz
Mar 1, 1982·Pharmacology, Biochemistry, and Behavior·A D ShermanF Petty
Jun 1, 1982·Pharmacology, Biochemistry, and Behavior·R J Katz
Jun 1, 1982·Pharmacology, Biochemistry, and Behavior·R J Katz, G Baldrighi
May 1, 1996·Pharmacology, Biochemistry, and Behavior·E FuchsC Hiemke
Nov 1, 1996·Physiology & Behavior·I Q Whishaw, J A Tomie
Dec 11, 1999·Psychopharmacology·A Dalvi, I Lucki
Jul 5, 2001·Physiology & Behavior·K Björkqvist
Aug 28, 2001·Brain Research. Brain Research Protocols·B Vollmayr, F A Henn
Nov 10, 2001·Pharmacology, Biochemistry, and Behavior·F BaiP Skolnick
Apr 5, 2002·Neuron·Eric J NestlerLisa M Monteggia
May 15, 2002·Trends in Pharmacological Sciences·John F CryanIrwin Lucki
Jul 18, 2002·Behavioural Pharmacology·P Willner, P J Mitchell
Oct 4, 2002·Biological Psychiatry·Eric J NestlerSteve Zalcman
Dec 5, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew HolmesJacqueline N Crawley
Feb 26, 2003·Psychopharmacology·Denis Joseph Paul DavidMichel Bourin
May 27, 2003·Human Psychopharmacology·Michael F O'Neil, Nicholas A Moore

❮ Previous
Next ❯

Citations

Oct 12, 2012·Psychopharmacology·Ming LiuChang-Xi Yu
Apr 25, 2012·Neurobiology of Disease·Thibault RenoirAnthony J Hannan
Jan 13, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Iulia TothDavid A Slattery
Mar 13, 2012·Pharmacological Reviews·Anita E Autry, Lisa M Monteggia
Jul 3, 2013·Biochemical Pharmacology·Paul McGonigle
Jun 17, 2014·Pharmacology, Biochemistry, and Behavior·Pao-Yen LinTsu-Kung Lin
Sep 17, 2014·ILAR Journal·Charles V Vorhees, Michael T Williams
Sep 26, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Liping ChenDongmei Duan
May 7, 2013·Expert Opinion on Investigational Drugs·Lokesh PathakAshish Dhir
Sep 1, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert W GouldCarrie K Jones
Feb 18, 2016·Neural Plasticity·Hui QiaoXin-Ming Ma
Feb 22, 2012·Neuroscience and Biobehavioral Reviews·Kanwar VirdeeJeffrey W Dalley
Dec 24, 2011·Behavioural Brain Research·S Josefin DahlbomSvante Winberg
Sep 14, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Matthew J RobsonRae R Matsumoto
Jun 7, 2011·Pharmacology & Therapeutics·Francesca CalabreseMarco A Riva
Mar 1, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Antonio Preti
Oct 13, 2015·Pharmacology, Biochemistry, and Behavior·Zhi-Kun QiuJi-Sheng Chen
Mar 20, 2016·Molecular Neurobiology·Raffaella AlòMarcello Canonaco
Jan 30, 2014·Journal of Midwifery & Women's Health·Aleeca F BellC Sue Carter
Oct 11, 2011·Experimental Neurology·Carol A Shively, Stephanie L Willard
May 12, 2015·Neuroscience and Biobehavioral Reviews·Alejandro Higuera-MatasEmilio Ambrosio
May 29, 2014·Behavioural Brain Research·Nelly M Vega-RiveraErika Estrada-Camarena
Jun 26, 2013·Neuroscience and Biobehavioral Reviews·D Caroline BlanchardRobert J Blanchard
Jun 12, 2013·Neuropharmacology·E R WorkmanKimberly F Raab-Graham
Aug 22, 2013·Physiology & Behavior·Cyrilla H WidemanHelen M Murphy
Oct 17, 2013·The International Journal of Neuropsychopharmacology·Frederick Rohan WalkerPatrick D McGorry
Jul 2, 2014·Frontiers in Psychiatry·Joana E CoelhoLuísa V Lopes
Jul 30, 2014·Journal of Molecular Neuroscience : MN·Irit Gil-AdAbraham Weizman
Sep 5, 2015·Journal of Neuroinflammation·Cecilie Bay-RichterLena Brundin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.